BIOLASE, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 10.13 million compared to USD 10.47 million a year ago. Net loss was USD 6.49 million compared to USD 5.85 million a year ago.

Basic loss per share from continuing operations was USD 0.36 compared to USD 17.83 a year ago. Diluted loss per share from continuing operations was USD 0.36 compared to USD 17.83 a year ago.